by Peter Ciszewski | Sep 22, 2017
When faced with the decision on whether to forego life-sustaining medical treatment for a child, clear communication among family, patient and health care personnel is essential. That is a key recommendation in an AAP policy statement — updated from 1994 — that offers...
by Peter Ciszewski | Sep 22, 2017
Although experts agree that vaccination rates in schools need to improve, they disagree on the best way to make this happen, highlighting the sensitive issues that currently surround vaccinations. On one side of the debate are physicians like California State Senator...
by Peter Ciszewski | Sep 22, 2017
The American Academy of Pediatrics (AAP) is calling on healthcare providers to ensure all healthy newborns receive a hepatitis B vaccine within 24 hours of birth. Giving babies a hepatitis B shot shortly after birth is nothing new. However, the AAP’s previous...
by Peter Ciszewski | Sep 20, 2017
Alnylam Pharmaceuticals announced today that the APOLLO Phase 3 study of patisiran, an investigational RNAi therapeutic being developed for patients with hereditary ATTR amyloidosis with polyneuropathy, met its primary efficacy endpoint and all secondary endpoints....
by Peter Ciszewski | Sep 15, 2017
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Aliqopa (copanlisib) for the treatment of adult patients with relapsed FL who have received at least two prior systemic therapies. Accelerated approval was granted for this indication...
